Medicare Enrolled

Dr. Sabeen Najam, MD

Rheumatology · Baytown, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1610 W BAKER RD STE C, Baytown, TX 77521
2814227179
In practice since 2007 (18 years)
NPI: 1124222708 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Najam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Najam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Najam

Dr. Sabeen Najam is a rheumatology in Baytown, TX, with 18 years in practice. Based on federal Medicare data, Dr. Najam performed 211,539 Medicare services across 1,433 unique beneficiaries.

Between the years covered by Open Payments, Dr. Najam received a total of $15,914 from 44 pharmaceutical and/or device companies across 897 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Najam is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 4% volume in TX$ $15,914 industry payments

Medicare Practice Summary

Medicare Utilization ↗
211,539
Medicare services
Top 4% in TX for rheumatology
1,433
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~11,752 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)168,400$4$12
Golimumab infusion (Simponi Aria)17,650$10$50
Abatacept infusion (Orencia)16,925$34$76
Denosumab injection (Prolia/Xgeva)4,500$18$39
Office visit, established patient (30-39 min)1,196$95$255
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle988$59$101
Administration of chemotherapy into vein, 1 hour or less583$104$207
Steroid injection (triamcinolone)279$1$5
Administration of chemotherapy into vein, each additional hour127$21$45
Injection, methylprednisolone sodium succinate, up to 125 mg123$4$14
New patient office visit (45-59 min)120$118$350
Injection of additional new drug or substance into vein115$12$50
Injection, diphenhydramine hcl, up to 50 mg115$1$4
Drug injection, under skin or into muscle83$11$32
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less79$23$48
Aspiration and/or injection of fluid large joint using ultrasound guidance67$83$185
Joint injection, major joint63$50$165
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less60$52$98
Injection, methylprednisolone acetate, 80 mg53$9$25
Aspiration and/or injection of fluid from small joint13$44$116
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
16.4% high complexity
83.0% medium
0.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$15,914
Total received (2018-2024)
Avg $2,273/year across 7 years
Top 23% in TX for rheumatology
44
Companies
897
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,914 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,208
2023
$2,724
2022
$2,448
2021
$2,196
2020
$1,939
2019
$2,231
2018
$2,169

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,942
GlaxoSmithKline, LLC.
$1,375
PFIZER INC.
$1,234
UCB, Inc.
$1,110
Mallinckrodt Hospital Products Inc.
$1,029
Janssen Biotech, Inc.
$978
Novartis Pharmaceuticals Corporation
$948
Horizon Therapeutics plc
$931
AstraZeneca Pharmaceuticals LP
$761
Lilly USA, LLC
$649
Aurinia Pharma U.S., Inc.
$537
ABBVIE INC.
$452
AbbVie Inc.
$396
Radius Health, Inc.
$387
GENZYME CORPORATION
$375
E.R. Squibb & Sons, L.L.C.
$340
AbbVie, Inc.
$330
Mallinckrodt LLC
$309
Genentech USA, Inc.
$265
Mallinckrodt Enterprises LLC
$261
ANI Pharmaceuticals, Inc.
$197
Horizon Pharma plc
$185
Organon LLC
$169
TerSera Therapeutics LLC
$142
Celgene Corporation
$78
Boehringer Ingelheim Pharmaceuticals, Inc.
$67
Fresenius Kabi USA, LLC
$63
Sobi, Inc
$45
Merck Sharp & Dohme Corporation
$45
MEDEXUS PHARMA, INC.
$43
Organon Llc
$42
Kiniksa Pharmaceuticals International, plc
$38
Exeltis, USA Inc.
$24
Alexion Pharmaceuticals, Inc.
$23
Actelion Pharmaceuticals US, Inc.
$21
Iroko Pharmaceuticals, LLC
$15
Antares Pharma, Inc.
$15
Zyla Life Sciences
$15
ASSERTIO THERAPEUTICS, Inc.
$14
Boston Scientific Corporation
$14
Hikma Pharmaceuticals USA
$13
Ironwood Pharmaceuticals, Inc
$13
DePuy Synthes Sales Inc.
$13
MEDAC PHARMA, INC.
$11
Top 3 companies account for 28.6% of total payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUEXIS · DUZALLO · EVENITY · EVUSHELD · Enbrel · FORTEO · GENERAL - PAIN MANAGEMENT · HADLIMA · HUMIRA · Humira · IDACIO · INFLECTRA · KEVZARA · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · NUCALA · OFEV · OPSUMIT · ORENCIA · OTREXUP · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Quzyttir · RAYOS · REMICADE · RENFLEXIS · REYVOW · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TIVORBEX · TREMFYA · Tavneos · Tymlos · VIMOVO · XELJANZ · ZORVOLEX · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $8 per 100 Medicare services performed
Looking for a rheumatology in Baytown?
Compare rheumatologys in the Baytown area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
18
Per 100K population
0.4
County median income
$73,104
Nearest hospital
HOUSTON METHODIST BAYTOWN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Najam is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Najam experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Najam performed 168,400 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Najam receive payments from pharmaceutical companies?
Yes. Dr. Najam received a total of $15,914 from 44 companies across 897 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Najam's costs compare to other rheumatologys in Baytown?
Dr. Najam's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Najam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →